Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (211-220 of 565) with videos related to

Pageof 57
Sort By:
American Journal of Nephrology|September 5, 2016
Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal OutcomesNishank Jain, Thomas Carmody, Abu T Minhajuddin, et al.
Nature Methods|June 11, 2013
Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradationDanielle L Swaney, Pedro Beltrao, Lea Starita, et al.
Archives of General Psychiatry|December 8, 2010
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorderRoy H Perlis, Rudolf Uher, Michael Ostacher, et al.
The Journal of Clinical Psychiatry|November 19, 2015
A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of IllnessLewis L Judd, Pamela J Schettler, A John Rush, et al.
The Biochemical Journal|July 26, 2012
RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activationMadhurima Saha, Audrey Carriere, Mujeeburahiman Cheerathodi, et al.
Biological Psychiatry|June 29, 2004
One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studiesA John Rush, Madhukar Trivedi, Thomas J Carmody, et al.
The Journal of Clinical Psychiatry|November 26, 2002
The impact of treatment-resistant depression on health care utilization and costsWilliam H Crown, Stan Finkelstein, Ernst R Berndt, et al.
Molecular & Cellular Proteomics : MCP|June 14, 2005
Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modulesYi Zhang, Alejandro Wolf-Yadlin, Phillip L Ross, et al.
Depression and Anxiety|October 30, 2018
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluationNancy De La Garza, A John Rush, Michael O Killian, et al.
The American Journal of Psychiatry|February 5, 2016
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar DepressionJan Fawcett, A John Rush, John Vukelich, et al.
Pageof 57

Showing results (211-220 of 565) with videos related to

Sort By:
Pageof 57
American Journal of Nephrology|September 5, 2016
Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal OutcomesNishank Jain, Thomas Carmody, Abu T Minhajuddin, et al.
Nature Methods|June 11, 2013
Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradationDanielle L Swaney, Pedro Beltrao, Lea Starita, et al.
Archives of General Psychiatry|December 8, 2010
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorderRoy H Perlis, Rudolf Uher, Michael Ostacher, et al.
The Journal of Clinical Psychiatry|November 19, 2015
A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of IllnessLewis L Judd, Pamela J Schettler, A John Rush, et al.
The Biochemical Journal|July 26, 2012
RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activationMadhurima Saha, Audrey Carriere, Mujeeburahiman Cheerathodi, et al.
Biological Psychiatry|June 29, 2004
One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studiesA John Rush, Madhukar Trivedi, Thomas J Carmody, et al.
The Journal of Clinical Psychiatry|November 26, 2002
The impact of treatment-resistant depression on health care utilization and costsWilliam H Crown, Stan Finkelstein, Ernst R Berndt, et al.
Molecular & Cellular Proteomics : MCP|June 14, 2005
Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modulesYi Zhang, Alejandro Wolf-Yadlin, Phillip L Ross, et al.
Depression and Anxiety|October 30, 2018
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluationNancy De La Garza, A John Rush, Michael O Killian, et al.
The American Journal of Psychiatry|February 5, 2016
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar DepressionJan Fawcett, A John Rush, John Vukelich, et al.
Pageof 57